Array BioPharma competitorsClear all

Array BioPharma's top competitors include Paion, Skyepharma, Circassia and Affimed N.V..
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
Skyepharma
Skyepharma
Skyepharma is a drug delivery company developing oral and inhalation products.
Circassia
Circassia
Circassia is a specialty biopharmaceutical company focused on developing novel immunotherapies
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date
Founding Date
1998
Founding Date
2000
Founding Date
1996
Founding Date
2006
Founding Date
2000
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Boulder, US HQ
Cambridge, US
Chicago, US
Detroit, US
Houston, US
Miami, US
Morrisville, US
see more
Locations
Aachen, DE HQ
Mönchengladbach, DE
Cambridge, GB
Locations
Saint-Quentin-Fallavier, FR HQ
Locations
Oxford, GB HQ
Bad Homburg Vor Der Höhe, DE
Uppsala, SE
London, GB
Morrisville, US
Locations
Heidelberg, DE HQ
Employees
Employees
29843% increase
Employees
3218% decrease
Employees
1513% decrease
Employees
350
Employees
1371270% increase
Valuation ($)
Valuation ($)
10.7 b
Valuation ($)
185.9 m
Valuation ($)
N/A
Valuation ($)
116.5 m
Valuation ($)
279.7 m
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
733358
Alexa Website Rank
N/A
Alexa Website Rank
273036
Alexa Website Rank
319782
Employee Rating
Employee Rating
3.5
Employee Rating
N/A
Employee Rating
5
Employee Rating
3.6
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
£95.9m (FY, 2015)
Revenue (est.)
£17k (FY, 2016)
Revenue (est.)
$21.4m (FY, 2019)
Cost of goods
Cost of goods
$59.4m (FY, 2018)
Cost of goods
N/A
Cost of goods
£43.1m (FY, 2015)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$114.4m (FY, 2018)
Gross profit
N/A
Gross profit
£52.8m (FY, 2015)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($147.7m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
£17k (FY, 2016)
Net income
($32.4m) (FY, 2019)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 15.2m
Total funding raised
N/A
Total funding raised
$ 122.8m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Paion
HQ
Aachen, DE
Employees
32↓ 18% decrease

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.

View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR

Skyepharma is a drug delivery company developing oral and inhalation products.

View company
Circassia
HQ
Oxford, GB
Employees
350

Circassia is a specialty biopharmaceutical company focused on developing novel immunotherapies

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
137

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company